Literature DB >> 283899

Bone scanning in management of metastatic osteogenic sarcoma.

A R Siddiqui, H N Wellman, R M Weetman, W L Smith.   

Abstract

Bone scan findings are presented from five consecutive cases of metastatic osteogenic sarcoma. Every patient had pulmonary metastases which concentrated the bone imaging radiopharmaceutical to some degree. In one patient, the diagnosis of pulmonary metastasis was made prior to our seeing any radiographic abnormalities. The mechanism by which skeletal imaging agents localize in pulmonary lesions is not clear. Unsuspected skeletal metastases were also discovered on scans in two patients, both of whom had normal radiographs. Diagnosis of hypertrophic pulmonary osteoarthropathy was made in one patient with normal radiographs. These findings indicate that bone scans as well as radiographs should be performed routinely in preoperative staging and followup of patients with osteogenic sarcoma.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 283899     DOI: 10.1097/00003072-197901000-00003

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

Review 1.  Paediatric nuclear medicine.

Authors:  A Piepsz; I Gordon; K Hahn
Journal:  Eur J Nucl Med       Date:  1991

Review 2.  Role of radionuclide studies in paediatric orthopaedic practice: a review.

Authors:  H Carty; R Owen
Journal:  J R Soc Med       Date:  1985-06       Impact factor: 5.344

3.  Detection of a brain metastasis from osteosarcoma with 99mTc-methylene diphosphonate bone scanning.

Authors:  A T Ozarda; J R Legaspi; T P Haynie
Journal:  Eur J Nucl Med       Date:  1983

4.  Bone scanning in the child and young adult. Part I.

Authors:  I P Murray
Journal:  Skeletal Radiol       Date:  1980-02       Impact factor: 2.199

5.  The value of radionuclide bone imaging in selected patients with osteogenic sarcoma metastatic to lung.

Authors:  D R Kirks; T A McCook; D F Merten; D C Sullivan
Journal:  Pediatr Radiol       Date:  1980-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.